vimarsana.com

Latest Breaking News On - Molecular docking - Page 3 : vimarsana.com

Speeding up drug discovery with diffusion generative models

"Unusual Tetrahydropyridoindole-Containing Tetrapeptides with Human Nic" by Xuewen Hou, Changlong Li et al.

Chemical investigation of the psychrophilic fungus Pseudogymnoascus sp. HDN17-933 derived from Antarctica led to the discovery of six new tetrapeptides psegymamides A–F (1–6), whose planar structures were elucidated by extensive NMR and MS spectrometric analyses. Structurally, psegymamides D–F (4–6) possess unique backbones bearing a tetrahydropyridoindoles unit, which make them the first examples discovered in naturally occurring peptides. The absolute configurations of structures were unambiguously determined using solid-phase total synthesis assisted by Marfey’s method, and all compounds were evaluated for their inhibition of human (h) nicotinic acetylcholine receptor subtypes. Compound 2 showed significant inhibitory activity. A preliminary structure–activity relationship investigation revealed that the tryptophan residue and the C-terminal with methoxy group were important to the inhibitory activity. Further, the high binding affinity of compound 2 to hα4β2 was expla

Antarctica
Molecular-docking
Nicotinic-acetylcholine-receptors
Sychrophilic-fungus
Solid-phase-synthesis
Etrahydropyridoindoles-unit
Etrapeptides

A Potential Basis for a Cure for Coronavirus Found

The compound Salen effectively binds to a number of SARS CoV 2, the virus that causes COVID-19, proteins. The findings pave the way to developing new therapeutics to fight coronavirus.

Anna-marinovich
Damir-safin
Urfu-damir-safin
Synthesis-laboratory-of-ural-federal-university
Kurgan-state-university
Technologies-of-ural-federal-university
Innovation-center
Optical-properties
Ural-federal-university
Tyumen-state-university
Polycyclic-aromatic
Research-engineer

Developing novel inhibitors of BRD4 to fight leukaemia with RECEPTOR.AI SaaS Platform

RECEPTOR.AI SaaS platform for drug discovery Our AI-based drug discovery platform allows virtual screening of billions of chemical compounds in just a few hours

United-kingdom
London
City-of
Drug-target-interactions
Molecular-docking
Brd-4

Developing novel inhibitors of BRD4 to fight leukaemia with RECEPTOR.AI SaaS Platform

Developing novel inhibitors of BRD4 to fight leukaemia with RECEPTOR.AI SaaS Platform
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
London
City-of
Alan-nafiiev
Drug-target-interactions
Molecular-docking
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.